Partnering Webinars
-
US Bioanalytical Services To Support Your Program Success
1/9/2023
CMIC’s skilled researchers provide deep expertise in small and large molecule bioanalysis, biomarker services and oligonucleotide bioanalysis expertise.
-
Sky-High Inflation And The Great Resignation: The Impact On Clinical Site Budgeting
11/17/2022
When it comes to negotiating budgets for a clinical trial, sponsors, CROs and sites all have the same goal: to run the study. Yet just like most business relationships, the conflict comes in what defines a fair price for services rendered. Now, with inflation at its highest rate in four decades and attrition rates at clinical research sites exceeding most industries, developing fair marketing value (FMV) for investigator grants is more contentious than ever.
-
The IQVIA Investigator Site Portal
11/15/2022
Understand why companies are standardizing operations on a purpose-built, proven platform that empowers sites to succeed and provides sponsors with helpful insights.
-
Trial Safety Measures: DXA For Bone Mineral Density Testing
10/14/2022
DXA remains the gold standard test for bone mineral density assessments. Listen in for information about how DXA scans work, who should get one, and whether their use will become more widespread.
-
Benefits Of Good Sample Preparation For The Bioanalytical Laboratory
10/13/2022
Explore a break down of the common types of sample preparation and where the benefits can be added with the use of solid-phase extraction (SPE).
-
Are Clinical Sites Seeing Cost Reductions As A Result Of DCTs?
9/28/2022
When the COVID-19 pandemic hit the U.S. in March 2020, many drug developers were caught by surprise. With clinics overwhelmed by COVID patients and the reluctance of some patients to venture out to those clinics, many trials faced the prospect of being delayed or canceled. Decentralized clinical trials (DCTs) and hybrid trials, which can take studies from the clinics to the patients, seemed to be the solution to keep things on track.
-
The Intelligent CRO Choice For Oncology, Rare Disease, And Cell And Gene Therapy Trials
9/27/2022
We are Cmed, a global CRO where technology meets expertise in oncology, cell & gene therapy, and rare disease.
-
Is Data Quality A Concern When Conducting Trials In APAC?
9/26/2022
The Asian-Pacific (APAC) region is one of the fastest growing areas for clinical trials. There are many benefits to conducting trials in the region, including low cost, ease of regulatory compliance, a growing patient population, and the presence of top clinical institutions. The APAC CRO market was valued at $7.6 billion in 2021 and is forecasted to reach $12 billion by 2025.
-
What Are The Timelines To Start A Clinical Trial In China?
9/26/2022
The Asian-Pacific (APAC) region is one of the fastest growing areas for clinical trials. There are many benefits to conducting trials in the region, including low cost, ease of regulatory compliance, a growing patient population, and the presence of top clinical institutions. The APAC CRO market was valued at $7.6 billion in 2021 and is forecasted to reach $12 billion by 2025
-
Cost Savings Of Conducting Clinical Trials In The APAC Region
9/26/2022
The Asian-Pacific (APAC) region is one of the fastest growing areas for clinical trials. There are many benefits to conducting trials in the region, including low cost, ease of regulatory compliance, a growing patient population, and the presence of top clinical institutions. The APAC CRO market was valued at $7.6 billion in 2021 and is forecasted to reach $12 billion by 2025.